News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2021 EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI Michael O'Riordan October 15, 2021
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011